🇺🇸 FDA
Patent

US 8834871

Immunoglobulin molecules with improved characteristics

granted A61KA61K2039/505A61K47/6803

Quick answer

US patent 8834871 (Immunoglobulin molecules with improved characteristics) held by The Board of Regents of the University of Texas System expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K47/6803, A61K49/0058, A61K51/1075